TPO and autoimmune thrombocytopenic purpura: Although it seems that in patients with ITP there is an increase in the megakaryocytic mass in the marrow, it has been proven that this does not occur in all patients, and furthermore, it is not an increase that justifies the loss of the inversed balance between TPO levels and the number of platelets (or platelet/megakaryocyte mass).